References
Estey E, Hoth D, Leyland-Jones B, Marsoni S, Wittes R (1984) Therapeutic results in phase I studies (abstract). Proc Am Soc Clin Oncol 3:35
Laetz T, Silberman G (1991) Reimbursement policies constrain the practice of oncology. JAMA 266:2996–2999
Moertel CG (1991) Off-label drug use for cancer therapy and national health care priorities. JAMA 266:3031–3032
Pappas PC, Lavin PT, Ross SD, Gold JE, Osband ME (1992) Marked discrepancy between survival and tumor response endpoints in cancer clinical trials (abstract). Proc Am Soc Clin Oncol 11:156
Author information
Authors and Affiliations
Additional information
The “Journal of Cancer Research and Clinical Oncology” publishes in loose succession “Editorials” and “Guest editorials” on current and/or controversial problems in experimental and clinical oncology. These contributions represent exclusively the personal opinion of the author The Editors
Rights and permissions
About this article
Cite this article
Markman, M. Beyond palliative chemotherapy: providing hope in an era of unrealistic expectations and medical-care rationing. J Cancer Res Clin Oncol 119, 74–75 (1992). https://doi.org/10.1007/BF01209659
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01209659